Optimising care for children with kidney disease

Field	Value	Language
dc.contributor.author	Caskey, Fergus J.
dc.contributor.author	Morton, Rachael L.
dc.date.accessioned	2023-02-15T01:58:31Z
dc.date.available	2023-02-15T01:58:31Z
dc.date.issued	2017	en
dc.identifier.uri	https://hdl.handle.net/2123/30031
dc.description.abstract	The theme for World Kidney Day in 2016 was “kidney disease and children: act early to prevent it”. Given the adverse effect of renal replacement therapy—dialysis and transplantation—on quality of life and health care resources, few would disagree with this ambition. For some children, however, end-stage kidney disease cannot be avoided and its effects have to be managed and outcomes optimised. With increasing fiscal pressures on health services in many settings around the world, the Article in The Lancet by Nicholas Chesnaye and colleagues looking at macroeconomics and survival on renal replacement therapy in Europe is timely.	en
dc.publisher	Elsevier	en
dc.relation.ispartof	The Lancet	en
dc.rights	Creative Commons Attribution-NonCommercial-NoDerivatives 4.0	en
dc.subject	Optimising Care	en
dc.subject	Children with Kidney Disease	en
dc.title	Optimising care for children with kidney disease	en
dc.type	Article	en
dc.identifier.doi	10.1016/S0140-6736(17)30267-2
usyd.faculty	SeS faculties schools::Faculty of Medicine and Health::NHMRC Clinical Trials Centre	en
workflow.metadata.only	Yes	en

Associated file/s

There are no files associated with this item.